XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Operating expenses        
Research and development $ 831,844 $ 313,133 $ 1,595,219 $ 1,883,808
General and administrative 1,295,642 227,980 3,520,281 1,222,616
Total operating expenses 2,127,486 541,113 5,115,500 3,106,424
Loss from operations (2,127,486) (541,113) (5,115,500) (3,106,424)
Other expense        
Interest expense (235,822) (1,591,244) (572,912)
Change in redemption value (76,501) (980,245)
Total other expense (312,323) (1,591,244) (1,553,157)
Net loss $ (2,127,486) $ (853,436) $ (6,706,744) $ (4,659,581)
Net loss per share:        
Basic and diluted $ (0.18) $ (0.13) $ (0.60) $ (0.73)
Weighted average number of common shares outstanding:        
Basic and diluted 11,531,899 6,357,314 11,248,041 6,357,314